🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9320786

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9316646

Anti-human ROR1 antibodies

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9314532

Drug delivery vehicle

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9314494

Cranberry xyloglucan oligosaccharide composition

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9314448

Method of inhibiting ABCG2 and other treatment methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9310368

High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9309237

HIV inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9308163

Methods of treating and preventing diseases and disorders of the central nervous system

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9303044

7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of throm

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9296790

Methods and compositions for protein delivery

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9290512

Activators of human pyruvate kinase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9283233

Method for on-demand contraception

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9278090

Methods of preventing the development of mucositis and related disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9278089

Method of treating HCV infection with a small molecule CHK2 inhibitor

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9277748

Agonist/antagonist compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273136

Fully human anti-human NKG2D monoclonal antibodies

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273124

Monoclonal antibodies that react with the capsule of Bacillus anthracis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273121

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9272023

Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9266960

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of sa

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9266928

Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved ant

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9265818

Genetically modified Babesia parasites expressing protective tick antigens and uses thereo

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9259463

Chlamydia vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9254319

Compositions and methods for generating an immune response

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted